Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0G4B
|
||||
| Drug Name |
3-{Cyclobutyl[3-(6-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide
|
||||
| Synonyms |
CHEMBL520661
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H27F2N3O2
|
||||
| Canonical SMILES |
NC(=O)c1ccc(F)c2OCC(Cc12)N(CCCc3c[nH]c4cc(F)ccc34)C5CCC5
|
||||
| InChI |
InChI=1S/C25H27F2N3O2/c26-16-6-7-19-15(13-29-23(19)11-16)3-2-10-30(17-4-1-5-17)18-12-21-20(25(28)31)8-9-22(27)24(21)32-14-18/h6-9,11,13,17-18,29H,1-5,10,12,14H2,(H2,28,31)
|
||||
| InChIKey |
BAIWKWLUINJQMA-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.